New diabetes drug may replace insulin jabs

The new potential drugs have a completely different action than the most commonly prescribed anti-diabetic, Metformin, which acts on the liver to reduce glucose production.

PTI
Melbourne, Publish Date: May 20 2017 1:02AM | Updated Date: May 20 2017 1:02AM
New diabetes drug may replace insulin jabsRepresentation Pic

Scientists are developing a new safe, effective diabetes drug that could spell the end for painful insulin jabs.

Researchers led by the University of Adelaide in Australia have for the first time shown how potential anti- diabetic drugs interact with their target in the body at the molecular level. 

The new potential drugs have a completely different action than the most commonly prescribed anti-diabetic, Metformin, which acts on the liver to reduce glucose production.

They target a protein receptor known as PPARgamma found in fat tissue throughout the body, either fully or partially activating it in order to lower blood sugar by increasing sensitivity to insulin and changing the metabolism of fat and sugar.